Arcturus Therapeutics Holdin (ARCT) Hedge Fund & Institutional Holdings (Q2 2026)

ARCT ranks #3932 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ARCT is a disclosed holding of Cathie Wood (ARK Investment Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.1% of that fund's own 13F portfolio.

135 institutions disclose a position in ARCT, but none treat it as a major bet — even nVerses Capital, LLC, its most concentrated holder, allocates just 0.4% of its own portfolio to it.

Cliff Asness has added to its ARCT position for two straight quarters, increasing it by $4.3M to reach $4.5M today.

Jane Street Group, LLC has trimmed its ARCT position for two straight quarters, cutting it by $3.3M while still holding $100.9K.

ARCT is up 3.1% today, and institutions have been net buyers of $3.9M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ARCT reported a net loss of $93.3M over the trailing twelve months.

• Not yet profitable — net loss of $93.3M over the trailing twelve months
• Revenue declined 76.0% year over year
• Net income declined year over year, from -$60.2M to -$93.3M
• Operating cash flow was negative, using $74.3M in cash
• Current ratio of 6.64x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.27x equity — within a conventional range